Open AccessPrimary Hepatoid Adenocarcinoma of the Lung: A Systematic Literature Review
Author(s) -
Zhitao Chen,
Chenchen Ding,
Ting Zhang,
Yahui He,
Guoping Jiang
Publication year - 2022
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s364465
Subject(s) - medicine , adenocarcinoma , proportional hazards model , gefitinib , lung , oncology , disease , etiology , lung cancer , adenocarcinoma of the lung , gastroenterology , surgery , cancer , epidermal growth factor receptor
Hepatoid adenocarcinoma (HAC) of the lung (HAL) is a rare and aggressive extrahepatic adenocarcinoma with an unknown etiology and unfavorable prognosis, which is similar to the pathophysiological characteristics of hepatocellular carcinoma (HCC).